Based on our finding that overexpression of Rab37 mediated sustainable PD-1 PM presentation and T cell exhaustion, we thus proposed that the TIL populations of Rab37+/PD-1+/TIM3+/CD8+ T cells may be related to the adverse clinical responses in lung cancer patients. This evidence concerns the gene RAB37 and lung cancer.